Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 92%
filed 2026-06-24
The filing discloses post-acquisition integration progress following NextBoat's acquisition of Apex Marine Companies, completed on May 1, 2026. While the 8-K itself is filed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated M&A item, the press release centers on material developments stemming from the acquisition: inventory integration, sales performance (15 vessels sold), service expansion, facility consolidation, and $90,000 in monthly cost savings. The acquisition itself is a material event that would affect a reasonable investor's assessment of the company's operations and financial position.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-24
Massimo Group entered into a loan agreement with its Executive Chairman David Shan on June 23, 2026, creating a new direct financial obligation of up to $4 million at 4% interest, repayable June 22, 2027. This is disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and represents the creation of a new debt obligation. While the lender is a controlling shareholder, the substance is a debt issuance that materially affects the company's capital structure and financial obligations.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-24
EX-99.1
Gamehaus Holdings held an extraordinary general meeting of Class A shareholders to vote on amending the company's articles of association to increase the voting rights of Class B shares from 15 to 50 votes per share. The proposal would substantially increase Chairman Feng Xie's aggregate voting power from 76.7% to 91.3%, materially affecting the control structure and shareholder rights.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-24
This 6-K discloses the results of an extraordinary general meeting held on June 22, 2026, where shareholders voted on six resolutions. The primary material events are: (1) approval of an Asset Purchase Agreement to acquire Rantizo's drone-based technology assets for approximately $259.6 million in cash and stock (Resolution 1); (2) approval of a company name change to "Rantizo" (Resolution 2); and (3) approval of a 10x increase in authorized share capital (Resolution 3). All resolutions passed with overwhelming majorities. The disclosure of shareholder vote results on material transactions—particularly the acquisition and name change—is the core event type, though the filing also encompasses M&A activity approval and dilutive share issuance approval.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-24
EX-99.1
Rail Vision announces successful completion of ShuntingYard field testing with Israel Railways and a non-binding MOU with Railserve (a Marmon Rail Company) to integrate its technology into Railserve's commercial railyard safety system. These represent material operational and commercial milestones—product validation and partnership expansion—that advance the company's commercialization trajectory, but do not constitute a discrete M&A transaction, earnings release, or other named event type. The disclosure emphasizes customer validation and market traction for an early-stage technology company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
The filing discloses a private placement of 20,000,000 shares of common stock at $0.60 per share, generating approximately $12,000,000 in gross proceeds. The shares were issued under Section 4(a)(2) of the Securities Act and Regulation S to non-U.S. accredited investors. This is a classic unregistered equity issuance (dilutive_issuance), disclosed under Items 1.01 and 3.02, representing a material capital raise for a small-cap company trading on Nasdaq Capital Market.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
The filing discloses results of SHF Holdings' 2026 Annual Meeting of Stockholders held on June 17, 2026, under Item 5.07. The company reports voting outcomes for two matters: election of two Class II directors (Jonathon F. Niehaus and Sean Tonner) and ratification of Macias, Gini & O'Connell LLP as independent auditor for fiscal year 2026. All proposals were approved with required votes, making this a standard shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Restatement
confidence 95%
filed 2026-06-24
The Audit Committee concluded on June 24, 2026, that the Company's previously issued audited financial statements for fiscal year ended December 31, 2024, should no longer be relied upon due to an inadvertently failed recording of a $1,319,366 derivative liability related to convertible debt. The Company intends to correct this error by filing an amendment to the Original Filing, which is the hallmark of a financial restatement under Item 4.02.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
The filing discloses Item 5.07 results from Daxor Corporation's Annual Meeting held June 23, 2026, including the election of six directors and ratification of Bush & Associates, CPA as the independent registered public accounting firm. The voting tallies for each director and the auditor ratification are explicitly provided, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
6-K
Workforce Reduction
confidence 75%
filed 2026-06-24
EX-99.1
The exhibit discloses a "targeted operational restructuring" of the WalletKu subsidiary involving suspension of active business operations, "orderly workforce transitions," and allocation of up to US$150,000 for "employee severance liabilities." While the press release frames this as a strategic refocus on AI and Web3, the core disclosed action is an operational restructuring with associated workforce reduction and severance costs, which is the hallmark of a workforce_reduction event. The materiality is supported by the subsidiary's prior US$7.7M revenue and US$0.45M net loss, indicating a meaningful business segment being wound down.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-24
The 6-K discloses results of an extraordinary general meeting held on June 16, 2026, where shareholders voted on and approved four resolutions. The resolutions include a significant share reorganization (increase of authorized capital from 100 million to 50 billion shares, redesignation into Class A and Class B shares with differential voting rights), and adoption of amended memorandum and articles of association. This is a classic shareholder vote results disclosure under Item 5.07, and the share reorganization with dual-class voting structure is material to investors' assessment of voting control and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
The filing discloses results of an Extraordinary General Meeting held on June 24, 2026, where shareholders voted on seven proposals, including approval of a Business Combination Agreement with XDATA, a Reincorporation Merger, Nasdaq listing compliance, governance amendments, an incentive plan, and director appointments. All proposals passed with overwhelming support (3,205,004 votes for, 0 against on most proposals). This is a classic Item 5.07 shareholder vote results disclosure, and the underlying business combination is material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
The filing discloses results of Lucid Diagnostics' annual stockholder meeting held on June 24, 2026, including: (1) election of three Class B directors (Cox, Palumbo, Sparks) with detailed vote tallies; (2) approval of an amendment to increase authorized common shares from 300 million to 400 million shares; and (3) ratification of CBIZ CPAs P.C. as independent auditor. Item 5.07 explicitly governs shareholder vote results, and the 100-million-share authorization increase is material to investors assessing dilution risk and capital-raising capacity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
Item 5.07
PAVmed held its annual meeting of stockholders on June 24, 2026, at which shareholders elected two Class A directors (Ronald M. Sparks and Timothy Baxter), approved amendments to the Employee Stock Purchase Plan increasing available shares from 15,774 to 215,774, and ratified CBIZ CPAs P.C. as the independent auditor.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-24
The filing discloses a refinancing transaction (First Modification of Term Loan Agreement) on June 17, 2026, creating a new $2.33 million direct financial obligation with Cendera Bank maturing June 1, 2033. Although technically a modification of an existing loan, the 8-K Item 1.01 classification and the detailed disclosure of new material terms (interest rate structure, amortization, covenants, guaranty) indicate this is a material amendment creating substantively new debt obligations. The removal of the $2.5 million cash collateral reserve requirement and the interest rate swap arrangement further support materiality to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-24
Worksport entered into two registered direct offerings on June 17–18, 2026, issuing 208,333 shares at $1.20 per unit (with warrants) and 675,529 shares at $0.70 per share, totaling approximately $722,870 in gross proceeds. The offerings include dilutive equity issuances and warrant grants with cashless exercise features, characteristic of a registered direct offering (PIPE-like structure). This is a material capital raise that dilutes existing shareholders and is disclosed under Item 1.01 (Entry into a Material Definitive Agreement).
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-06-24
Item 3.01 discloses that on March 23, 2026, NYSE American notified the Company it was not in compliance with continued listing standards under Section 1003(f)(v) due to stock price falling below $0.10, and trading was halted. The Company is undertaking a 1-for-60 reverse split to regain compliance. This is a classic delisting-risk disclosure—the exchange has notified the registrant of non-compliance and the registrant is taking corrective action to avoid delisting.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-24
The filing discloses a Cooperation Agreement between CEA Industries and YZi Labs (a major shareholder holding 2.15M shares and warrants for 21.2M additional shares) that fundamentally restructures the company's governance. The agreement includes: (1) appointment of three YZi Labs directors (Ling Zhang, Alex Odagiu, Matthew Roszak) to expand the Board to six members; (2) formation of a CEO Search Committee to identify a new CEO by August 31, 2026; (3) appointment of Alex Odagiu as Interim President; (4) termination of YZi Labs' consent solicitation; and (5) customary standstill and voting agreements. While this involves multiple governance elements (director appointments, CEO search, board restructuring), the central event is a comprehensive governance settlement and board reconstitution driven by activist shareholder pressure, making it a material governance matter that does not fit neatly into the specific categories of exec_appointment or exec_departure alone.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 95%
filed 2026-06-24
The filing discloses a notice of acceleration and demand dated April 13, 2026, triggered by the Company's default on secured convertible debentures ($4.3M principal) issued November 1, 2024. The Company failed to make payments by November 2, 2025, and debenture holders have accelerated all sums due and initiated foreclosure proceedings on the Company's oil and gas leases in Martin County, Texas, scheduled for July 7, 2026. This is a classic covenant breach that accelerates a direct financial obligation and materially threatens the registrant's asset base and continued operations.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-06-24
Dr. Florent Heidet's employment and service as Chief Technology Officer and Head of Reactor Development was terminated effective June 22, 2026, with Board approval. While the filing also mentions James Walker's appointment as Interim Head of Reactor Development, the principal disclosed action centers on the departure of a named executive officer from a key technical leadership role at a nuclear technology company, making this primarily an exec_departure event.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-06-24
EX-99.1
Autozi announced execution of a Securities Purchase Agreement under which it issued convertible promissory notes totaling $5.25 million in gross proceeds, with an additional $2.5 million option. The notes are convertible into Ordinary Shares at a conversion price based on closing sale price at time of conversion. This is a dilutive equity issuance offered under Section 4(a)(2) and Regulation D exemptions, materially affecting shareholder equity and ownership structure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-24
Item 7.01
The filing discloses the Board of Directors' declaration of monthly "base" and quarterly "bonus" cash distributions to common shareholders of Prospect Floating Rate and Alternative Income Fund. The distributions are specified with record dates (June 26, 2026), payment dates (July 2, 2026), and per-share amounts ($0.02924 monthly base and $0.04723 quarterly bonus), representing a 14.96% annualized distribution rate. This is a routine but material dividend declaration typical of closed-end funds.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-24
Item 1.01
This is a material governance agreement between Oportun and Bradley L. Radoff and The Radoff Family Foundation that involves board composition changes (two Class I directors retiring by the 2026 annual meeting), standstill restrictions limiting the Radoff Parties to 4.9% ownership, voting agreements tying the Radoff Parties' votes to Board recommendations, and mutual non-disparagement provisions through 2028. While the agreement contemplates director retirements, the central disclosed action is the entry into a comprehensive governance and standstill agreement that materially constrains a significant shareholder's actions and board influence, making it a governance matter broader than a simple executive departure or appointment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-06-24
Item 8.01
The filing discloses the issuance of BBCMS Mortgage Trust 2026-5C42 Commercial Mortgage Pass-Through Certificates with an aggregate principal amount of $570,184,000 in public certificates and additional private certificates sold to underwriters and initial purchasers. This represents creation of new direct financial obligations secured by 37 commercial and multifamily mortgage loans, fitting the debt_issuance category. While technically structured as mortgage-backed securities rather than traditional debt, the economic substance is the issuance of debt instruments backed by mortgage collateral.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-24
Item 1.01
The filing discloses the issuance of Commercial Mortgage Pass-Through Certificates, Series 2026-5C9 pursuant to a Pooling and Servicing Agreement dated May 1, 2026. The Certificates represent beneficial ownership in a trust fund holding 29 fixed-rate mortgage loans and subordinate interests in commercial mortgage loans secured by 138 properties. This is a material securitization transaction creating direct financial obligations in the form of mortgage-backed securities, which falls squarely within debt_issuance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-24
EX-99.1
Blue Moon announces three significant operational milestones for its Nussir copper-silver-gold project: award of an EPC contract to MOMEK Services AS for the processing plant, approval of the Waste Management Plan and updated discharge permit by the Norwegian Environment Agency, and approval of the updated mine operating plan by the Norwegian Directorate of Mines. These represent material progress toward full-scale construction and production in Q4 2027, with the company noting that "permitting framework now complete" and "key construction contracts in place." While not a discrete M&A transaction, debt issuance, or other named event type, this disclosure of major project advancement and regulatory clearance is clearly operational and material to investors assessing the company's development trajectory.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-06-24
Item 8.01
News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transaction details including 8.4 million Class A shares and 76,679 Class B shares purchased on 24 June 2026 for approximately $212 million in aggregate consideration. Share repurchases constitute a form of capital return to shareholders and are classified as dividend_distribution events under the taxonomy, as they represent a return of capital to security holders alongside the company's intent to "enhance shareholder value."
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-24
Item 7.01
Elicio Therapeutics hosted a virtual key opinion leader event on June 24, 2026, presenting preliminary clinical data on ELI-002 7P in metastatic KRAS-driven pancreatic cancer, including observations of three patients achieving complete responses following ELI-002 7P treatment and subsequent nivolumab-based therapy. This disclosure highlights clinical progress and a planned Phase 1 combination study strategy for a lead product candidate. While the event itself is operational/strategic in nature (a KOL presentation), the underlying clinical data—particularly the 100% complete response rate in three patients and the hypothesis-generating findings supporting further development—would materially affect a reasonable investor's assessment of the company's pipeline and product potential. The disclosure is material because it provides significant clinical validation for a key development program, though it is not a formal earnings release, M&A activity, or other specifically-named event type.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 85%
filed 2026-06-24
Item 1.01
Chemours settled material PFAS emissions claims with the EPA and West Virginia Department of Environmental Protection, involving a $22.5 million civil penalty (with $15 million previously accrued) and $90 million in mitigation projects over 15 years, along with expansion of drinking water programs and site-related remediation actions across three major facilities.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-24
Item 2.02
Daktronics announced financial results for fiscal year and fourth quarter ended May 2, 2026, reporting record net sales of $838.7 million, record orders of $860.8 million, and full-year EPS of $0.92 compared to a loss per share of $0.21 in the prior year, representing material improvements in profitability and operational performance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-06-24
Item 8.01
The Board authorized an increase to the Company's share repurchase program, raising the total available authorization to $40.0 million, approved on June 22, 2026.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-24
Item 5.02
CAVA Group amended its Executive Severance Plan with material changes to eligibility, severance benefit conditions, offset provisions, and change-of-control standstill periods, affecting compensatory arrangements for directors and officers.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
CAVA Group disclosed final voting results from its June 22, 2026 annual meeting of stockholders, including election of two Class III directors (Brett Schulman and James D. White), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Iradimed's Annual Meeting of Stockholders held on June 23, 2026. The filing presents voting results for three proposals: (1) election of five directors (Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel, and James Hawkins), (2) ratification of RSM US LLP as independent auditor, and (3) advisory vote on named executive officer compensation. All three proposals passed with substantial majorities. This is a material governance event affecting investor understanding of board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder vote results from Foghorn's 2026 Annual Meeting of Stockholders held on June 24, 2026. The filing reports final voting tallies for four proposals: election of three Class III directors (Douglas Cole, Simba Gill, and B. Lynne Parshall), ratification of Deloitte & Touche LLP as auditor, advisory approval of named executive officer compensation, and advisory approval of voting frequency on executive compensation. The detailed vote counts for each proposal are the core content of Item 5.07.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-06-24
Item 8.01
JPMorgan Chase announced an intended increase in its quarterly common stock dividend from $1.50 to $1.65 per share for Q3 2026, along with authorization of a new $50 billion share repurchase program. While the filing also addresses regulatory capital matters (SCB and CET1 requirements), the primary disclosed action is the dividend increase and capital return program, which are material to shareholders and constitute a dividend_distribution event. The share repurchase program is a form of capital distribution and is explicitly highlighted in the press release headline.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder vote results from LanzaTech's 2026 Annual Meeting held on June 23, 2026, covering three proposals: election of Class III directors (Dorri McWhorter and Jim Messina), ratification of BDO USA, P.C. as independent auditor, and advisory approval of named executive officer compensation. The filing presents detailed voting tallies for each proposal, which is the core content of Item 5.07 (Submission of Matters to a Vote of Security Holders).
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-24
Item 7.01
JPMorgan Chase disclosed the results of its 2026 Dodd-Frank Act Stress Test (DFAST), a company-run stress test required by Federal Reserve regulations. The filing presents hypothetical capital projections, profit & loss forecasts, and loan loss estimates under a "Supervisory Severely Adverse Scenario" for the nine-quarter period 1Q26–1Q28. While this is a regulatory disclosure required under the DFAST Rule, it is material to investors as it demonstrates the firm's capital adequacy and resilience under severe economic stress conditions—key metrics for assessing financial stability and risk management. The disclosure is operational/regulatory in nature rather than a specific financial event (earnings, debt issuance, impairment, etc.), making `operational_other` the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-24
Item 5.07
Jushi Holdings held its 2026 Annual General and Special Meeting of Shareholders on June 24, 2026, with shareholders voting on four proposals: setting board size at five directors, electing five directors, ratifying auditors, and approving a special resolution to redomicile from British Columbia to Nevada. The redomiciliation vote is particularly material as it represents a significant corporate governance and jurisdictional change.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder voting results from C4 Therapeutics' Annual Meeting of Stockholders held on June 24, 2026, covering four proposals: election of Class III directors (Hirsch, Fawell, Koppikar), advisory vote on named executive officer compensation, ratification of KPMG LLP as independent auditor, and approval of an amendment to the 2020 Stock Option and Incentive Plan. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core disclosure, which is the hallmark of Item 5.07 shareholder vote results. This is material as it reflects stockholder approval of key governance and compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-24
Item 5.07
This is a clear disclosure of shareholder voting results from Wealthfront's 2026 Annual Meeting held on June 23, 2026. The filing reports final vote tallies for two proposals: election of Class I directors (David Fortunato and Andrew S. Rachleff) and ratification of Ernst & Young LLP as independent auditor. Both proposals passed with strong majorities, and the disclosure includes vote counts, broker non-votes, and abstentions as required under Item 5.07.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
HPS Corporate Capital Solutions Fund completed an unregistered private placement of approximately $16.91 million in common shares of beneficial interest across Class I and Class D shares, issued to accredited investors and non-U.S. persons pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-24
Item 7.01
The Fund declared regular distributions ranging from $0.1202 to $0.1390 per share depending on share class, plus an additional special distribution of $0.11 per share, with specified record and payment dates.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-24
Item 5.02
Ja-chin Audrey Lee resigned from her position as a Class C director of Spruce Power Holding Corporation effective immediately on June 17, 2026. This is a clear departure of a director, which is material to investors as it affects board composition and governance. The filing discloses no replacement appointment or compensatory arrangement, making the departure the principal disclosed action.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-24
Item 7.01
HPS Corporate Lending Fund declared regular and variable supplemental distributions to shareholders across multiple share classes on June 23, 2026, with per-share amounts ranging from $0.1849 to $0.2020, record date of June 30, 2026, and payment date on or about July 31, 2026.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-24
Item 8.01
The Fund reported its net asset value per share as of May 31, 2026, with aggregate NAV of $12.6 billion, portfolio fair value of $24.5 billion, and debt outstanding, along with an update on its ongoing public offering of up to $15.0 billion in shares approaching $14.0 billion in total consideration.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-24
Item 5.02
Douglas J. Cornille, Chief Growth Officer, is stepping down from his role effective June 24, 2026, and departing the Company effective September 1, 2026.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 95%
filed 2026-06-24
Item 8.01
The Company approved workforce realignment actions on June 24, 2026, designed to optimize operations, with expected annualized run-rate operating expense savings of $10–$12 million and one-time workforce realignment charges of approximately $6 million, primarily for severance and related benefits.
View raw filing on EDGAR →
8-K
Earnings release
confidence 94%
filed 2026-06-24
Item 2.02
Barnes & Noble Education announced preliminary unaudited financial results for fiscal year ended May 2, 2026, including full-year revenue guidance of $1.710–$1.720 billion (+6.2–6.8% YoY), net income expectations of $15–18 million (versus prior-year loss of $65.8 million), and Adjusted EBITDA guidance of $75–77 million (+26–30% YoY). The disclosure was made via press release at an Investor Day event.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-06-24
Item 8.01
The Board approved the company's first quarterly dividend of $0.08 per share, payable July 30, 2026 to shareholders of record on July 16, 2026, marking the commencement of a regular quarterly dividend program previously announced on March 10, 2026.
View raw filing on EDGAR →